Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Multiple Myeloma × treosulfan × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 10 Leukemia, Myeloid, Acute 10 Leukemia, Myelomonocytic, Chronic 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Hodgkin Disease 2 Uveal Melanoma 1 Shwachman-Diamond Syndrome 1 Prostatic Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hemoglobinuria, Paroxysmal 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Congenital amegakaryocytic thrombocytopenia 1 Congenital Abnormalities 1

Interventions

Dexamethasone 338 Lenalidomide 187 Bortezomib 187 Cyclophosphamide 166 Melphalan 124 Calcium Dobesilate 108 daratumumab 95 pomalidomide 69 fludarabine phosphate 69 carfilzomib 69 Peripheral Blood Stem Cell Transplantation 64 Filgrastim 56 Thalidomide 55 Busulfan 53 Mycophenolic Acid 52 Tacrolimus 45 Granulocyte Colony-Stimulating Factor 45 ixazomib 43 fludarabine 42 Whole-Body Irradiation 40 Cyclosporine 35 Etoposide 33 dexamethasone acetate 31 Antilymphocyte Serum 31 isatuximab 29 dexamethasone 21-phosphate 26 Prednisone 26 elotuzumab 25 Biopsy 25 auricularum 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05636787 2024-07-08

TreoMel

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡